GPS Wealth Strategies Group LLC Reduces Stock Position in Cardinal Health, Inc. (NYSE:CAH)

GPS Wealth Strategies Group LLC lessened its holdings in Cardinal Health, Inc. (NYSE:CAH) by 32.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 313 shares of the company’s stock after selling 149 shares during the quarter. GPS Wealth Strategies Group LLC’s holdings in Cardinal Health were worth $37,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Eastern Bank purchased a new position in Cardinal Health in the 3rd quarter worth about $25,000. Frazier Financial Advisors LLC increased its position in shares of Cardinal Health by 69.8% during the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after acquiring an additional 104 shares during the period. Hara Capital LLC bought a new stake in shares of Cardinal Health during the third quarter valued at approximately $31,000. AM Squared Ltd purchased a new stake in shares of Cardinal Health in the third quarter valued at approximately $33,000. Finally, Carolina Wealth Advisors LLC bought a new position in Cardinal Health in the third quarter worth approximately $47,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft lifted their target price on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research report on Monday, November 4th. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $132.00 to $142.00 and gave the company a “neutral” rating in a research report on Friday, January 24th. Wells Fargo & Company boosted their price target on shares of Cardinal Health from $127.00 to $135.00 and gave the company an “equal weight” rating in a report on Wednesday, January 29th. Finally, Barclays increased their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $135.64.

Cardinal Health Price Performance

Cardinal Health stock opened at $125.56 on Tuesday. The business has a fifty day moving average price of $122.11 and a 200-day moving average price of $114.53. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $132.84. The stock has a market capitalization of $30.33 billion, a price-to-earnings ratio of 23.43, a PEG ratio of 1.46 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.92 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.61%. Cardinal Health’s payout ratio is currently 37.69%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.